Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bafrekalant is a diazabicyclo-substituted imidazo[1,2-a]pyrimidine derivative that can be used to study sleep-related breathing disorders such as obstructive and central sleep apnoea and snoring.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 56,000 |
5 mg | 在庫あり | ¥ 137,000 |
10 mg | 在庫あり | ¥ 199,500 |
25 mg | 在庫あり | ¥ 296,000 |
50 mg | 在庫あり | ¥ 406,500 |
100 mg | 在庫あり | ¥ 548,500 |
500 mg | 在庫あり | ¥ 1,099,500 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 155,000 |
説明 | Bafrekalant is a diazabicyclo-substituted imidazo[1,2-a]pyrimidine derivative that can be used to study sleep-related breathing disorders such as obstructive and central sleep apnoea and snoring. |
分子量 | 531.05 |
分子式 | C29H31ClN6O2 |
CAS No. | 2256770-44-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 225.0 mg/mL (423.7 mM ), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bafrekalant 2256770-44-0 Others Inhibitor inhibitor inhibit